Doctor Survey Results Will Inform FDA Policy On Risk Communication
This article was originally published in The Tan Sheet
Executive Summary
Findings from an FDA survey of physicians about their use and perceptions of emerging drug risk information could add a new tenor to the debate about the value of communicating early risk signals